Free Trial

BTIG Research's Rating of Ardelyx on 11/9/2026

On November 9, 2026, BTIG Research updated its outlook on Ardelyx (NASDAQ:ARDX) with the action "Lower Price Target", setting a price target of $11.00. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from BTIG Research

DateCompanyAction
11/13/2026
Green Brick Partners, Inc. stock logo
GRBK
Green Brick Partners
Reiterated Rating
11/13/2026
MDxHealth SA stock logo
MXDHF
MDxHealth
Reiterated Rating
11/13/2026
Mondelez International, Inc. stock logo
MDLZ
Mondelez International
Reiterated Rating
11/13/2026
Omnicell, Inc. stock logo
OMCL
Omnicell
Reiterated Rating
11/13/2026
LGN stock logo
LGN
LGN
Lower Price Target
11/13/2026
ATI Inc. stock logo
ATI
ATI
Boost Price Target
More Ratings From BTIG Research